88 related articles for article (PubMed ID: 18080525)
1. [The clinical significance of immunohistochemically detectable Ki-67 protein in renal cell carcinoma].
Lazarev AF; Doroshenko VS; Varlamov SA
Vestn Ross Akad Med Nauk; 2007; (11):33-5. PubMed ID: 18080525
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma.
Visapää H; Bui M; Huang Y; Seligson D; Tsai H; Pantuck A; Figlin R; Rao JY; Belldegrun A; Horvath S; Palotie A
Urology; 2003 Apr; 61(4):845-50. PubMed ID: 12670587
[TBL] [Abstract][Full Text] [Related]
3. [Study of the prognostic value of DNA ploidy and proliferation index (Ki-67) in renal cell carcinoma with venous thrombus].
Rey D; Pfister C; Gobet F; Martinez S; Staerman F; Grise P
Prog Urol; 2003 Dec; 13(6):1300-6. PubMed ID: 15000303
[TBL] [Abstract][Full Text] [Related]
4. Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma.
Ronkainen H; Hirvikoski P; Kauppila S; Vaarala MH
Oncol Rep; 2011 Jan; 25(1):129-33. PubMed ID: 21109967
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of clinical and pathological factors for surgically treated localized clear cell renal cell carcinoma.
Teng J; Gao Y; Chen M; Wang K; Cui X; Liu Y; Xu D
Chin Med J (Engl); 2014; 127(9):1640-4. PubMed ID: 24791867
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell carcinoma.
Djordjevic G; Mozetic V; Mozetic DV; Licul V; Ilijas KM; Mustac E; Oguic R; Fuckar Z; Jonjic N
Pathol Res Pract; 2007; 203(2):99-106. PubMed ID: 17270362
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of Ki-67 expression in renal cell carcinomas.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K
Eur Urol; 1997; 31(3):350-5. PubMed ID: 9129930
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of Ki-67 immunostaining in nonmetastatic renal cell carcinoma.
de Riese WT; Crabtree WN; Allhoff EP; Werner M; Liedke S; Lenis G; Atzpodien J; Kirchner H
J Clin Oncol; 1993 Sep; 11(9):1804-8. PubMed ID: 7689094
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma.
Yildiz E; Gokce G; Kilicarslan H; Ayan S; Goze OF; Gultekin EY
BJU Int; 2004 May; 93(7):1087-93. PubMed ID: 15142169
[TBL] [Abstract][Full Text] [Related]
11. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
[TBL] [Abstract][Full Text] [Related]
12. MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis.
Mehdi MZ; Nagi AH; Naseem N
Int Braz J Urol; 2016; 42(6):1121-1128. PubMed ID: 27532114
[TBL] [Abstract][Full Text] [Related]
13. Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.
Dudderidge TJ; Stoeber K; Loddo M; Atkinson G; Fanshawe T; Griffiths DF; Williams GH
Clin Cancer Res; 2005 Apr; 11(7):2510-7. PubMed ID: 15814627
[TBL] [Abstract][Full Text] [Related]
14. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases.
Taki A; Nakatani Y; Misugi K; Yao M; Nagashima Y
Mod Pathol; 1999 Mar; 12(3):310-7. PubMed ID: 10102617
[TBL] [Abstract][Full Text] [Related]
15. Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment.
Zhang L; Yao L; Li X; Jewett MA; He Z; Zhou L
J Formos Med Assoc; 2016 Jun; 115(6):463-9. PubMed ID: 26058870
[TBL] [Abstract][Full Text] [Related]
16. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
Rodins K; Cheale M; Coleman N; Fox SB
Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
[TBL] [Abstract][Full Text] [Related]
17. Value of p53 expression, cellular proliferation, and DNA content as prognostic indicators in renal cell carcinoma.
Papadopoulos I; Rudolph P; Weichert-Jacobsen K
Eur Urol; 1997; 32(1):110-7. PubMed ID: 9266242
[TBL] [Abstract][Full Text] [Related]
18. Calponin h1 expression in renal tumor vessels: correlations with multiple pathological factors of renal cell carcinoma.
Islam AH; Ehara T; Kato H; Hayama M; Kobayashi S; Igawa Y; Nishizawa O
J Urol; 2004 Mar; 171(3):1319-23. PubMed ID: 14767341
[TBL] [Abstract][Full Text] [Related]
19. Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other.
Tollefson MK; Thompson RH; Sheinin Y; Lohse CM; Cheville JC; Leibovich BC; Kwon ED
Cancer; 2007 Aug; 110(4):783-90. PubMed ID: 17594714
[TBL] [Abstract][Full Text] [Related]
20. The MIB-1 tumor proliferation index in adult renal epithelial tumors with granular cytoplasm: biologic implications and differential diagnostic potential.
Tickoo SK; Amin MB; Linden MD; Zarbo RJ
Mod Pathol; 1998 Nov; 11(11):1115-21. PubMed ID: 9831210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
